OSCR vs. TRUP, KMPR, COLB, MC, HWC, VLY, IRT, FRHC, APLE, and PK
Should you be buying Oscar Health stock or one of its competitors? The main competitors of Oscar Health include Trupanion (TRUP), Kemper (KMPR), Columbia Banking System (COLB), Moelis & Company (MC), Hancock Whitney (HWC), Valley National Bancorp (VLY), Independence Realty Trust (IRT), Freedom (FRHC), Apple Hospitality REIT (APLE), and Park Hotels & Resorts (PK). These companies are all part of the "finance" sector.
Oscar Health (NYSE:OSCR) and Trupanion (NASDAQ:TRUP) are both finance companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, community ranking, dividends, analyst recommendations, institutional ownership and valuation.
Trupanion received 494 more outperform votes than Oscar Health when rated by MarketBeat users. Likewise, 66.41% of users gave Trupanion an outperform vote while only 53.85% of users gave Oscar Health an outperform vote.
Trupanion has a net margin of -4.03% compared to Oscar Health's net margin of -4.62%. Trupanion's return on equity of -15.19% beat Oscar Health's return on equity.
Oscar Health presently has a consensus price target of $13.50, suggesting a potential downside of 23.94%. Trupanion has a consensus price target of $33.20, suggesting a potential upside of 42.49%. Given Trupanion's higher possible upside, analysts plainly believe Trupanion is more favorable than Oscar Health.
In the previous week, Trupanion had 4 more articles in the media than Oscar Health. MarketBeat recorded 6 mentions for Trupanion and 2 mentions for Oscar Health. Oscar Health's average media sentiment score of 1.81 beat Trupanion's score of 0.57 indicating that Oscar Health is being referred to more favorably in the media.
75.7% of Oscar Health shares are owned by institutional investors. 25.5% of Oscar Health shares are owned by company insiders. Comparatively, 5.8% of Trupanion shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Oscar Health has a beta of 1.79, meaning that its share price is 79% more volatile than the S&P 500. Comparatively, Trupanion has a beta of 1.71, meaning that its share price is 71% more volatile than the S&P 500.
Trupanion has lower revenue, but higher earnings than Oscar Health. Trupanion is trading at a lower price-to-earnings ratio than Oscar Health, indicating that it is currently the more affordable of the two stocks.
Summary
Trupanion beats Oscar Health on 10 of the 18 factors compared between the two stocks.
Get Oscar Health News Delivered to You Automatically
Sign up to receive the latest news and ratings for OSCR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OSCR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Oscar Health Competitors List
Related Companies and Tools
